Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Minos Medical Inc.

This article was originally published in Start Up

Executive Summary

In the emerging field of natural orifice surgery, Minos Medical is taking a blended-risk approach by initially going after high-volume procedures that aren't complicated, and which are done laparoscopically today. The company's strategy is to develop the tools and gain experience in near-term markets that would position it for more advanced NOTES applications in the future. Minos has already launched its first product, called MegaChannel, a platform for delivering tools in and out of the bowel, the stomach, or the upper GI tract. According to the company, MegaChannel is the NOTES equivalent of cardiology's guiding catheter.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts